Monocyte response to bacterial toxins, expression of cell surface receptors, and release of anti-inflammatory cytokines during sepsis

Journal of Laboratory and Clinical Medicine

Volumn 128, Issue 6, 1996, Pages 594-600

  Astiz, Mark ^a   Saha, Dhanonjoy ^a   Lustbader, Dana ^a   Lin, Robert ^a   Rackow, Eric ^a  

^a ST VINCENT S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030369193     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(96)90132-8     Document Type: Article

References (42)

1. Greisman SE. Induction of endotoxin tolerance. In: Nowotny A, editor. Beneficial effects of endotoxins. New York: Plenum Press, 1983:149-78.
2. Mathison J, Virca G, Wolfson E, Tobias S, Glaser K, Ulevitch R. Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J Clin Invest 1990;85:1108-18.
3. Granowitz E, Porat R, Mier J, Orencole S, Kaplanski G, Lynch E, et al. Intravenous endotoxin suppresses the cytokine response of peripheral mononuclear cells of healthy humans. J Immunol 1993;151:1637-45.
4. Munoz C, Carlet J, Fitting C, Misset B, Bleriot J, Cavaillon J. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991;88:1747-54.
5. Ertel W, Kremer J, Kenney J, Steckholzer U, Jarrar D, Trentz O, et al. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995;85: 1341-7.
6. Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, et al. Mechanism of endotoxin desensitization: involvement of interleukin-10 and transforming growth factor β. J Exp Med 1995;181:1887-92.
7. Bogdan C, Nathan C. Modulation of macrophage function by transforming growth factor β, interleukin-4, and interleukin-10. Ann NY Acad Sci 1993;685:713-9.
8. Haas J, Baeuerle P, Riethmuller G, Ziegler-Heitbrock H. Molecular mechanisms in down regulation of tumor necrosis factor expression. Proc Natl Acad Sci 1990;87:9563-7.
9. Marchant A, Deviere J, DeGroote D, Vincent J, Goldman M. Interleukin-10 production during septicemia. Lancet 1994;343:707-8.
10. Lin R, Astiz M, Saxon J, Saha D, Rackow E. Relationship between plasma cytokine concentrations and leukocyte functional antigen expression in patients with sepsis. Crit Care Med 1994;22:1595-602.
11. Ertel W, Morrison M, Wang P, Ba Z, Ayala A, Chaudry I. Complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin, and interleukin. Ann Surg 1991; 214:141-8.
12. ACCP/SCCM Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-74.
13. Boyum A, Berg T, Blomhoff R. Fractionation of mammalian cells In: Rickwood D, editor. Iodinated density gradient media: a practical approach. Oxford, England: IRL Press, 1983: 147-71.
14. Bernstein I, Self S. Joint report of the myeloid section of the Second International Workshop on Human Leukocyte Differentiation Antigens. In: Reinherz E, Haynes B, Nadler L, Bernstein I, editors. Leukocyte typing II: human myeloid and hematopoietic cells. New York: Springer-Verlag 1984;3:1-25.
15. Lawrence D. Identification and activation of latent transforming growth factor beta. Methods Enzymol 1991;198:327-36.
16. Lin Y, Astiz M, Saxon J, Rackow E. Altered leukocyte immunophenotypes in septic shock. Studies of HLA-DR, CD11b, CD14, and IL-2R expression. Chest 1993;104:857-63.
17. Loken M, Brosnan J, Bach B, Ault K. Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 1990;11:453-9.
18. McCall C, Grosso-Wilmoth L, LaRue K, Guzman R, Cousart S. Tolerance to endotoxin-induced expression of interleukin-1 β gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest 1993;91:853-61.
19. Zukerman S, Evans G, Snyder M, Roeder W. Endotoxin-macrophage interaction: post-transnational regulation of tumor necrosis factor expression. J Immunol 1989;143: 1223-7.
20. Astiz M, Galera A, Saha D, Rackow E. Monophosphoryl lipid A protects against gram-positive sepsis and tumor necrosis factor. Shock 1994;2:271-4.
21. Card C, Jasjua R, Gustafson G. Activation of arachidonic acid metabolism in mouse macrophages by bacterial amphiphiles. J Leukocyte Biol 1994;56:723-8.
22. Casey L, Balk R, Bone R. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993;119:771-8.
23. Pinsky M, Vincent JL, Deviere J, Alegre M, Kahn R, Dupont E. Serum cytokine levels in human septic shock. Chest 1993; 103:565-75.
24. Bjork L, Anderson J, Ceska M, Andersson U. Endotoxin and staphylococcal aureus enterotoxin A induce different patterns of cytokines. Cytokine 1992;4:513-9.
25. Wenisch C, Parschalk B, Burgmann H, Looareesuwan S, Graninger W. Decreased levels of TGF-β in patients with acute Plasmodium falciparum malaria. J Clin Immunol 1995; 15:69-73.
26. Grossman D, Lamphear J, Mollick J, Betley M, Rich R. Dual roles for class II major histocompatiblity complex molecules in staphylococcal enterotoxin-induced cytokine production and in vivo toxicity. Infect Immun 1992;50:5190-6.
27. Matsuyama S, Koide Y, Yoshida T. HLA class II molecule-mediated signal transduction mechanism responsible for the expression of interleukin-1β and tumor necrosis factor-α genes induced by staphylococcal superantigen. Eur J Immunol 1993;23:3194-202.
28. Matic M, Simon S. Tumor necrosis factor release from lipoploysaccharide-stimulated human monocytes: lipopolysaccharide tolerance in vitro. Cytokine 1991;3:576-83.
29. Castagna M, Takai Y, Kaibuchi K, Sano K, Kikkawa U, Nishizuka Y. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem 1982;257:7847-51.
30. Gonwa T, Picker L, Raff H, Goyert S, Silver J, Stobo J. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an Ia determinant distinct from HLA-DR. J Immunol 1983;130:706-11.
31. De Waal Malefyt R, Abrams J, Bennett B, Figdor C, de Vries J. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
32. Snyder D, Beller D, Unanue E. Prostagladins modulate macrophage Ia expression. Nature 1982;299:163-5.
33. Gallinaro R, Naziri W, McMasters K, Peyton J, Cheadle W. Alteration of mononuclear cell immune-associated antigen expression, interleukin-1 expression, and antigen presentation during intra-abdominal infection. Shock 1994;1:130-4.
34. Appel S, Wellhausen S, Montgomery R, DeWeese C, Polk H. Experimental and clinical significance of endotoxin-dependant HLA-DR expression on monocytes. J Surg Res 1989; 47:39-44.
35. Hershman M, Cheadle W, Wellhausen S, Davidson P, Polk H. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patients. Br J Surg 1990; 77:204-7.
36. Birkenmaier C, Hong Y, Horn J. Modulation of endotoxin receptor (CD14) in septic patients. J Trauma 1992;32: 473-9.
37. Kruger C, Schutt C, Obertacke U, Joka T, Muller F, Knoller J, et al. Serum CD14 levels in polytraumatized and severely ill burned patients. Clin Exp Immunol 1991;85:297-301.
38. Bogdan C, Vodovotz Y, Nathan C. Macropahge deactivation by interleukin-10. J Exp Med 1991;174:1549-55.
39. Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth-factor β. Nature 1988; 334:260-2.
40. 2 in immune suppression following injury. Ann Surg 1991;214:253-63.
41. Assoian R, Fleurdelys B, Stevenson H, Miller P, Madtes D, Raines E, et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987;84:6020-4.
42. Junger W, Hoyt D, Redl H, Liu F, Loomis W, Davies J, et al. Tumor necrosis factor antibody treatment of septic baboons reduces the production of sustained T-cell suppressive factors. Shock 1995;3:173-8.